Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.72 AUD | +0.58% | -4.44% | -10.65% |
03-19 | Cyclopharm's Technegas Device Carries Out Imaging of First US Patients | MT |
03-18 | Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.65% | 106M | |
+11.45% | 221B | |
+9.19% | 186B | |
+14.80% | 137B | |
+27.59% | 109B | |
-0.04% | 63.09B | |
+13.69% | 52.68B | |
+4.86% | 50.86B | |
+7.64% | 42.53B | |
+7.57% | 37.76B |
- Stock Market
- Equities
- CYC Stock
- News Cyclopharm Limited
- US FDA Confirms Receipt of Cyclopharm's Response Submission for Inhalable Imaging Agent